This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
05 October 2018 11:58
A result overview of the evaluation that closed on 18 April 2018 is now available under the "Topic conditions and documents" section.
27 April 2018 09:57
The submission of proposals to the 21 topics of H2020-SC1-2018-Single-Stage-RTD closed on 18 April 2018. A total of 324 proposals were submitted. The number of proposals per topic is as follows:
- SC1-HCO-12-2018 (CSA): 3
01 March 2018 11:36
Notice regarding page limits applicable to proposals: applicants are allowed to remove the page break in the cover page of the template for the technical annex, i.e. the proposal text can start on the cover page.
07 November 2017 00:30
The submission session is now available for: SC1-HCO-12-2018(CSA)
TOPIC : Innovation in healthcare - a CSA towards using pre-commercial procurement and public procurement of innovative solutions in healthcare systems
| Topic identifier: | SC1-HCO-12-2018 | ||
| Publication date: | 27 October 2017 | ||
| Types of action: | CSA Coordination and support action | ||
| DeadlineModel: Planned opening date: |
single-stage 07 November 2017 |
Deadline: | 18 April 2018 17:00:00 |
| Time Zone : (Brussels time) | |||
Innovative solutions for healthcare have the potential to improve patient care in European healthcare setting. Integrated care[1] principles allow care for patients to be better coordinated, and jointly planned by the health and social care professionals across vertically and horizontally relevant preventive and curative services. To respond to changing organisation of care and support the transition of hospital services towards a patient-centred integrated care model, healthcare providers are encouraged to join forces and create demand for such innovations through public joint procurement, serving the triple aim of healthcare: better care experience, better care outcomes, and more efficient care.
Implementation of timely and correct diagnostics for infectious diseases that will speed up the identification of the causative infectious disease pathogens, resistance and drug susceptibility is crucial for tailoring the antimicrobial treatment to ensure appropriate antimicrobial drug use and to reduce unnecessary prescriptions. As innovative rapid diagnostics are significantly more expensive than culture-based diagnostics that are widely used since decades, the uptake of these new tests in hospitals and especially primary care centres has been limited. To respond to this clinical and public health need and to facilitate the uptake of innovative rapid diagnostics for infectious diseases into healthcare practice, contracting authorities can act together to create demand for such innovations through public joint procurement.
However, before joint innovation procurement can be undertaken, first the cross-border cooperation between interested healthcare procurers must be established to counter fragmentation of delivering innovative solutions in healthcare settings[2].
Scope:The objective of this coordination and support action (CSA) is to create a Europe-wide consortium of healthcare providers and public procurers in the health and social care sector that define together unmet procurement needs to implement innovative solutions in healthcare.
The consortium should prepare future procurement topics to conduct:
Activities supported by this CSA should include the following aspects:
The Commission considers that a proposal requesting an EU contribution between EUR 1.5 and 2 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.
Cross-cutting Priorities:[1]Integrated care considers initiatives seeking to improve outcomes of care by overcoming issues of fragmentation through linkage or coordination of services of different providers along the continuum of care
[2]This call topic is complementary but separate from DTH-10-2019-2020 for digital solutions for health and care services
Horizon 2020 - is a Framework Programme for Research and Technological Development, and is created by the European Union in order to support and encourage research in the European Research Area (ERA). This is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020). By coupling research and innovation, Horizon 2020 is helping to achieve this with its emphasis on excellent science, industrial leadership and tackling societal challenges. The goal is to ensure Europe produces world-class science, removes barriers to innovation and makes it easier for the public and private sectors to work together in delivering innovation. The Horizon 2020 programme running from 2014 to 2020 has a €79 billion budget (a 46% increase over FP7).
It is structured around three core pillars:
Type of projects: mostly grants, no supplies, no works.
In order to see Horizon 2020 opportunities on DevelopmentAid, please click here.
Covers healthcare services, public health systems, and activities aimed at promoting physical and mental well-being.
Encompasses initiatives that improve how organizations plan, source, and manage the purchase of goods and services to ensure value for money, compliance, and supplier performance.
